Inhibition of Endothelin (ET-1) Induced Pressor Responses by the Endothelin (ETA) Receptor Antagonist FR139317 in the Pithed Rat

Key Result

FR139317 dose-dependently (0.05-1 mg/kg) inhibited the magnitude and duration of the ET-1 induced pressor response in the pithed rat without influencing the initial depressor response.

Key Points

• The aim is to investigate the effects of FR139317 on endothelin-1 induced blood pressure changes in pithed rats.
• Pithed Sprague-Dawley rats were used for testing the efficacy of FR139317 on ET-1 induced blood pressure changes.
• FR139317 was administered at varying doses of 0.025 mg/kg to 1 mg/kg to assess its dose-dependent effects on pressor response.
• An intravenous bolus of ET-1 (800 pmoles/kg) was used to evaluate pressor responses before and after FR139317 treatment.
• FR139317 showed no significant effect at 0.025 mg/kg, but dose dependently inhibited ET-1 induced pressor responses at doses of 0.05-1 mg/kg.
• The antagonist effectively reduced both the magnitude and duration of the ET-1 induced blood pressure increase.
• The initial depressor response to ET-1 remained unchanged by the administration of FR139317.